BioMed Central:
Migraine is alargely inherited neurological disorder leading to a combination of symptomsincluding headache, visual and aural effects. As any long-time migrainesufferer will tell you, migraine pain is debilitating, and the currenttreatments are not always very effective. How well do we really understand themechanism of migr (Read More)
BioMed Central:
All BioMed Central's journals strive to ensure the integrity of the scientific record and, as members of the Committee on Publication Ethics (COPE), have procedures in place to help prevent covert duplicate (redundant) publication. Non-transparent duplication within the citable literature is academically unethical and, even (Read More)
BioMed Central:
A team led by Sihoun Hahn and Jay Shendure from Seattle Children’s Research Institute and the University of Washington present a molecular diagnostic tool for mitochondrial disease in their article titled “Next generation sequence analysis for mitochondrial disorders”, recently published in Genome Medicine. This is the 100t (Read More)
Archives of Internal Medicine current issue:
Background Reports of clinical trials usually emphasize efficacy results, especially when results are statistically significant. Poor safety reporting can lead to misinterpretation and inadequate conclusions about the interventions assessed. Our aim was to describe the reporting of harm-related results from randomized cont (Read More)
The Lancet:
Disclosure of financial associations of authors of articles published in biomedical journals has become common practice. The information provided in these disclosures helps the reader to understand the relationships between the authors and various commercial entities that may have an interest in the information reported in (Read More)
BioMed Central:
BioMed Central is once again publishing the Journal of Medical Case Reports (JMCR) and Cases Journal. Since their inception both these journals, which currently provide over 2000 freely accessible case reports, have received widespread recognition and high quality submissions from across the medical community. Through thei (Read More)
BioMed Central:
BMC Medical Ethics, Journalof Inflammation and Pediatric Rheumatology have all recently been accepted for indexing byThomson Reuters and are on course to receive their first Impact Factors.BMC Medical Ethics will receive its first impact factor in June 2012, and currently has an unofficial Impact Factor of 1.68. It is the 3 (Read More)
BioMed Central:
Two new articles in Genome Medicine discuss US healthcare reform and the recent UK House of Lords report on genomic medicine, and examine their potential consequences for genomic research and for medical care.Each issue of Genome Medicine features a Musings column by David G Nathan and Stuart Orkin, who tackle a variety of (Read More)
BioMed Central:
Several members of the BioMed Central Editorialteam had the pleasure of attending the annual conference held by the NationalCancer Research Institute (NCRI) in Birminham UK, October 4-7th, 2009,and of meeting up with several Editorial Board members while there. The conference and the concurrent workshopabout Sage bionetwor (Read More)
BioMed Central:
When a genomic research project is planned, its medical applications may not be immediately apparent, and the subsequent process of translation to the clinic may be fraught with difficulties. Two new Correspondence articles in Genome Medicine provide insights into the challenges of moving systems biology research towards (Read More)
BioMed Central:
BMC Medical Genomics has now been accepted for tracking by Thompson Reuters and will get its first impact factor in June 2010. This announcement further emphasizes the successful path that BMC Medical Genomics has taken to this date. Since its launch in January 2008, BMC Medical Genomics has published more than 100 high qu (Read More)
The Lancet:
In 1996, representatives from two independent initiatives to improve the quality of reports of randomised trials met to develop a single coherent guideline, which was published as the CONsolidated Standards Of Reporting Trials (CONSORT) statement in the same year and revised in 2001. Similar initiatives to make the reportin (Read More)
BioMed Central:
"ChIP'ing the mammalian genome: technical advances and insights into functional elements", a Review recently published in Genome Medicine, examines the power of chromatin immunoprecipitation methods for genomic studies. Chromatin immunoprecipitation, or ChIP, cross-links DNA with its associated proteins before using specifi (Read More)
BioMed Central:
Key genes involved in the development of resistance to methotrexate chemotherapy are reported in “Networking of differentially expressed genes in human cancer cells resistant to methotrexate”, a research article recently published in Genome Medicine.Carlos Ciudad and colleagues used networking analysis of genes mutually der (Read More)
Journal of Clinical Investigation -- New Articles:
When Brian J. Druker was a boy, he wanted to be a baseball player; Nicholas B. Lydon had his sights set on flying jets; Charles L. Sawyers knew early on that he wanted to practice medicine. Decades later, this trio (Figure 1) would collaborate to revolutionize the treatment of chronic myelogenous leukemia (CML). Today, the (Read More)